HER-2 Antibody Inhibitor Therapy Refactory
1 clinical trials · Condition
◉ Watch HER-2 Antibody Inhibitor Therapy Refactory
| Record | Firm | Date |
|---|---|---|
| Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors (NCT01935843) | Chinese PLA General Hospital | 2013-09-01 |
Track HER-2 Antibody Inhibitor Therapy Refactory automatically
Every clearance here is in the API, with alerts when new ones post.